ABcann Global (TSXV: ABCN) (OTC: ABCCF) - Investor Dashboard

➔ ABcann Global
Sector: Healthcare
Industry: Legal Cannabis
Country: Canada
Employees:  41
Established: 2012
CEO: Barry Fishman

ABcann – Cannabis Facilities

Vanluven Facility

  • 14,500-square-foot facility in Napanee, Ontario
  • Production capacity: 1,000 kilograms annually
  • Completely licensed and fully operational

Kimmett Facility

  • Land owned for future build-out
  • 150,000-square-foot facility planned for Napanee, Ontario
  • Production capacity: 20,000 kilograms annually

Future Expansion

  • 65 acres ready for development
  • 100% ownership
  • Estimated 1.2 million square feet
  • Power/water/waste infrastructure in place

ABcann – Cannabis Clinics

Harvest Medicine

ABcann completed the acquisition of Harvest Medicine (HMed) in February 2018. HMed opened its 3,500-square-foot clinic in Calgary, Alberta in January 2017.

Visit ABcann Global, Inc.

New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. ABcann Global, Inc. is a client of NCV Media, LLC. Read our full disclaimer.